Spyre Therapeutics (SYRE) Tax Provisions (2021 - 2025)
Spyre Therapeutics (SYRE) reported Tax Provisions of -$15000.0 for Q1 2025, down 146.88% on a YoY basis from $32000.0 in Q1 2024, and down 1600.0% quarter-over-quarter from $1000.0 in Q4 2024.
Spyre Therapeutics (SYRE) Tax Provisions (2021 - 2025) Analysis & Trends
Spyre Therapeutics has reported Tax Provisions for 5 years, with the latest figure at -$15000.0 in Q1 2025.
- For the quarter ending Q1 2025, Tax Provisions fell 146.88% year-over-year to -$15000.0; the trailing twelve-month figure through Dec 2025 stood at -$15000.0 (down 129.41% YoY), and the FY2025 full-year result was -$15000.0, down 129.41% from the prior year.
- Tax Provisions for Q1 2025 stood at -$15000.0, down from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $92000.0 in Q2 2021, with the low at -$209000.0 in Q3 2022.
- Historically, Tax Provisions has averaged -$846.15 across 5 years, with a median of $9000.0 in 2022.
- Annual changes were most pronounced in 2022 — Tax Provisions plunged 903.85% — and 2024, when it soared 500.0%.
- Spyre Therapeutics' Tax Provisions stood at $23000.0 in 2021, then soared by 65.22% to $38000.0 in 2022, then plunged by 92.11% to $3000.0 in 2023, then slumped by 66.67% to $1000.0 in 2024, then sank by 1600.0% to -$15000.0 in 2025.
- The last three Tax Provisions figures came in at -$15000.0 (Q1 2025), $1000.0 (Q4 2024), and $18000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Spyre Therapeutics | 6.95 Bn | 6.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | -209,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 92,000.00 |